MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morel, Y.
Right arrow Articles by Barouki, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morel, Y.
Right arrow Articles by Barouki, R.

Vol. 57, Issue 6, 1158-1164, June 2000

A Repressive Cross-Regulation between Catalytic and Promoter Activities of the CYP1A1 and CYP2E1 Genes: Role of H2O2

Yannick Morel, Isabelle de Waziers, and Robert Barouki

Institut National de la Santé et de la Recherche Médicale U490, Université Paris V-René Descartes, Centre Universitaire des Saints-Pères, Paris, France

Cytochrome P450 enzymes catalyze the first step of the metabolism and subsequent elimination of hydrophobic xenobiotics. However, the activity of some isoforms, among them CYP1A1 and CYP2E1, may result in cellular insults such as oxidative stress and activation of procarcinogen compounds into reactive metabolites. The regulation of the expression of these enzymes is therefore important. We have previously shown that the CYP1A1 gene promoter was repressed by oxidative stress. We show here that the CYP2E1 gene promoter is down-regulated by exogenous H2O2 addition and glutathione depletion. It is also repressed by the transfection of a CYP2E1 expression vector, which elicits an intracellular H2O2 generation. This autoregulation is limited by catalase (which catalyzes the catabolism of H2O2), thus implying H2O2 as a mediator of the negative feedback mechanism. Furthermore, we observed that the activity of CYP1A1 resulting either from the stimulation of the endogenous gene by benzo[a]pyrene treatment or from the transfection of an expression vector, repressed the activity of the CYP2E1 gene promoter. Conversely, CYP2E1 overexpression repressed the activity of the CYP1A1 gene promoter. In both cases, catalase and a specific inhibitor of one enzyme prevented the repression of the other. This suggests that the generation of H2O2 during the catalytic cycle of these enzymes is a mediator of the cross-regulatory mechanisms. These novel repressive mechanisms of autoregulation and cross-regulation using H2O2 as a common mediator may limit the potential toxicity resulting from high cytochrome P450 activity within the cell.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Marchand, R. Barouki, and M. Garlatti
Regulation of NAD(P)H:Quinone Oxidoreductase 1 Gene Expression by CYP1A1 Activity
Mol. Pharmacol., April 1, 2004; 65(4): 1029 - 1037.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
C. L. Merrill, H. Ni, L. W. Yoon, M. A. Tirmenstein, P. Narayanan, G. R. Benavides, M. J. Easton, D. R. Creech, C. X. Hu, D. C. McFarland, et al.
Etomoxir-Induced Oxidative Stress in HepG2 Cells Detected by Differential Gene Expression Is Confirmed Biochemically
Toxicol. Sci., July 1, 2002; 68(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. I. Couroucli, S. E. Welty, R. S. Geske, and B. Moorthy
Regulation of Pulmonary and Hepatic Cytochrome P4501A Expression in the Rat by Hyperoxia: Implications for Hyperoxic Lung Injury
Mol. Pharmacol., March 1, 2002; 61(3): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Morel, X. Coumoul, A. Nalpas, and R. Barouki
Nuclear Factor I/CCAAT Box Transcription Factor trans-Activating Domain Is a Negative Sensor of Cellular Stress
Mol. Pharmacol., April 13, 2001; 58(6): 1239 - 1246.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics